AMENDED AND RESTATED EXECUTIVE Employment AgreementExecutive Employment Agreement • June 7th, 2022 • Outlook Therapeutics, Inc. • Biological products, (no disgnostic substances) • New Jersey
Contract Type FiledJune 7th, 2022 Company Industry JurisdictionThis Amended and Restated Executive Employment Agreement dated as of June 2, 2022 (“Agreement”) is by and between Lawrence A. Kenyon (“Executive”) and Outlook Therapeutics, Inc. (“Company”).
EXECUTIVE Employment AgreementExecutive Employment Agreement • December 23rd, 2021 • Outlook Therapeutics, Inc. • Biological products, (no disgnostic substances) • New Jersey
Contract Type FiledDecember 23rd, 2021 Company Industry JurisdictionThis Executive Employment Agreement dated as of December 21, 2021 (“Agreement”) is by and between Terry Dagnon (“Executive”) and Outlook Therapeutics, Inc. (“Company”).
EXECUTIVE Employment AgreementExecutive Employment Agreement • December 23rd, 2021 • Outlook Therapeutics, Inc. • Biological products, (no disgnostic substances) • New Jersey
Contract Type FiledDecember 23rd, 2021 Company Industry JurisdictionThis Executive Employment Agreement dated as of December 21, 2021 (“Agreement”) is by and between Jeff Evanson (“Executive”) and Outlook Therapeutics, Inc. (“Company”).
EXECUTIVE Employment AgreementExecutive Employment Agreement • July 30th, 2021 • Outlook Therapeutics, Inc. • Biological products, (no disgnostic substances) • New Jersey
Contract Type FiledJuly 30th, 2021 Company Industry JurisdictionThis Executive Employment Agreement dated as of July 27, 2021 (“Agreement”) is by and between Lawrence A. Kenyon (“Executive”) and Outlook Therapeutics, Inc. (“Company”).
EXECUTIVE Employment AgreementExecutive Employment Agreement • October 26th, 2018 • Oncobiologics, Inc. • Biological products, (no disgnostic substances) • New Jersey
Contract Type FiledOctober 26th, 2018 Company Industry JurisdictionThis Executive Employment Agreement dated as of October 22, 2018 (“Agreement”) is by and between Lawrence A. Kenyon (“Executive”) and Oncobiologics, Inc. (“Company”).
EXECUTIVE Employment AgreementExecutive Employment Agreement • January 5th, 2017 • Oncobiologics, Inc. • Biological products, (no disgnostic substances) • New Jersey
Contract Type FiledJanuary 5th, 2017 Company Industry JurisdictionThis Executive Employment Agreement dated as of February 22, 2016 (“Agreement”) is by and between Kogan K. Bao, Ph.D. (“Executive”) and Oncobiologics, Inc. (“Company”).
EXECUTIVE Employment AgreementExecutive Employment Agreement • April 27th, 2016 • Oncobiologics, Inc. • Biological products, (no disgnostic substances) • New Jersey
Contract Type FiledApril 27th, 2016 Company Industry JurisdictionThis Executive Employment Agreement dated as of February 24, 2016 (“Agreement”) is by and between Elizabeth A. Yamashita (“Executive”) and Oncobiologics, Inc. (“Company”).
EXECUTIVE Employment AgreementExecutive Employment Agreement • April 27th, 2016 • Oncobiologics, Inc. • Biological products, (no disgnostic substances) • New Jersey
Contract Type FiledApril 27th, 2016 Company Industry JurisdictionThis Executive Employment Agreement dated as of February 18, 2016 (“Agreement”) is by and between Lawrence A. Kenyon (“Executive”) and Oncobiologics, Inc. (“Company”).
EXECUTIVE Employment AgreementExecutive Employment Agreement • April 27th, 2016 • Oncobiologics, Inc. • Biological products, (no disgnostic substances) • New Jersey
Contract Type FiledApril 27th, 2016 Company Industry JurisdictionThis Executive Employment Agreement dated as of February 22, 2016 (“Agreement”) is by and between Kenneth M. Bahrt, M.D. (“Executive”) and Oncobiologics, Inc. (“Company”).
EXECUTIVE Employment AgreementExecutive Employment Agreement • April 27th, 2016 • Oncobiologics, Inc. • Biological products, (no disgnostic substances) • New Jersey
Contract Type FiledApril 27th, 2016 Company Industry JurisdictionThis Executive Employment Agreement dated as of February 22, 2016 (“Agreement”) is by and between Pankaj Mohan, Ph.D. (“Executive”) and Oncobiologics, Inc. (“Company”).